Chemoinformaics analysis of 4 – (2,6,6, - trimethyl – 1- cyclohexen – 3- buten – 2 – one
| Molecular Weight | 192.302 | nRot | 2 |
| Heavy Atom Molecular Weight | 172.142 | nRig | 8 |
| Exact Molecular Weight | 192.151 | nRing | 1 |
| Solubility: LogS | -3.816 | nHRing | 0 |
| Solubility: LogP | 3.535 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 35.8479 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.61 |
| Synth | 2.719 |
| Natural Product Likeliness | 2.09 |
| NR-PPAR-gamma | 0.173 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.962 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.615 |
| MDCK | 0.0000233 |
| BBB | 0.107 |
| PPB | 0.938446 |
| VDSS | 2.526 |
| FU | 0.063162 |
| CYP1A2-inh | 0.446 |
| CYP1A2-sub | 0.869 |
| CYP2c19-inh | 0.365 |
| CYP2c19-sub | 0.922 |
| CYP2c9-inh | 0.083 |
| CYP2c9-sub | 0.798 |
| CYP2d6-inh | 0.301 |
| CYP2d6-sub | 0.871 |
| CYP3a4-inh | 0.027 |
| CYP3a4-sub | 0.586 |
| CL | 1.704 |
| T12 | 0.611 |
| hERG | 0.029 |
| Ames | 0.089 |
| ROA | 0.497 |
| SkinSen | 0.805 |
| Carcinogencity | 0.815 |
| EI | 0.923 |
| Respiratory | 0.973 |
| NR-Aromatase | 0.24 |
| Antiviral | Yes |
| Prediction | 0.54998 |